-transparent.png){kind=logo}
The mechanism of bone, calcium, phosphorus and proteins abnormalities observed in hyperthyroidism is rather complex and as yet not wholly understood. Increased serum osteocalcin was recently reported in hyperthyroid patients and its decrease after 4-8 months of treatment. Osteocalcin was measured by RIA in the sera of 211 women and 18 men with thyroid diseases. The patients were divided into 3 groups according to diagnosis: I. polynodular goitre and subacute thyroiditis (59 women, 5 men); II. Graves' disease (70 women, 3 men) and III. thyroid cancer, after treatment by surgery and 131I (82 women, 10 men). The osteocalcin levels in the sera of these patients were: 2.97 +/- 2.63 ng/ml (mean +/- SD) for the women and 3.56 +/- 2.10 ng/ml for the men in the 1st group; 16.31 +/- 11.34 ng/ml for the women and 12.75 +/- 6.09 ng/ml for the man in the IInd group and, 1.01 +/- 0.60 ng/ml for the women and 0.78 +/- 0.46 ng/ml for the men in the IIIrd group. No differences were found between the osteocalcin concentrations in the hyperthyroid female patients treated with antithyroid drugs (no = 58) and the non-treated hyperthyroid women (no = 12): 16.22 +/- 11.40 ng/ml vs 16.74 +/- +/- 11.53 ng/ml. These data suggest that bone resorption stimulated by endogenous thyroid-hormones is a rather resistant processus, persisting even after 6-8 mos of associated anti-thyroid therapy. Further are analyzed the possible causes of the subnormal osteocalcin levels observed in patients with thyroid cancer treated by surgery and radioisotope, whose suppression therapy was discontinued 2-3 weeks before blood sampling.(ABSTRACT TRUNCATED AT 250 WORDS)
L Simionescu, and
L Dumitriu, and
V Dimitriu, and
D Zamfir-Grigorescu, and
G Câmpean, and
E Dumitriu, and
E Balmeş, and
M Simescu, and
E Gudovan, and
H Ursu
March 1992,
Paraplegia,
L Simionescu, and
L Dumitriu, and
V Dimitriu, and
D Zamfir-Grigorescu, and
G Câmpean, and
E Dumitriu, and
E Balmeş, and
M Simescu, and
E Gudovan, and
H Ursu
February 1990,
Bone and mineral,
L Simionescu, and
L Dumitriu, and
V Dimitriu, and
D Zamfir-Grigorescu, and
G Câmpean, and
E Dumitriu, and
E Balmeş, and
M Simescu, and
E Gudovan, and
H Ursu
January 1991,
Acta medica Austriaca,
L Simionescu, and
L Dumitriu, and
V Dimitriu, and
D Zamfir-Grigorescu, and
G Câmpean, and
E Dumitriu, and
E Balmeş, and
M Simescu, and
E Gudovan, and
H Ursu
January 1991,
The American journal of gastroenterology,
L Simionescu, and
L Dumitriu, and
V Dimitriu, and
D Zamfir-Grigorescu, and
G Câmpean, and
E Dumitriu, and
E Balmeş, and
M Simescu, and
E Gudovan, and
H Ursu
January 1989,
Journal of cancer research and clinical oncology,
L Simionescu, and
L Dumitriu, and
V Dimitriu, and
D Zamfir-Grigorescu, and
G Câmpean, and
E Dumitriu, and
E Balmeş, and
M Simescu, and
E Gudovan, and
H Ursu
January 2010,
Autoimmunity reviews,
L Simionescu, and
L Dumitriu, and
V Dimitriu, and
D Zamfir-Grigorescu, and
G Câmpean, and
E Dumitriu, and
E Balmeş, and
M Simescu, and
E Gudovan, and
H Ursu
July 2012,
Orvosi hetilap,
L Simionescu, and
L Dumitriu, and
V Dimitriu, and
D Zamfir-Grigorescu, and
G Câmpean, and
E Dumitriu, and
E Balmeş, and
M Simescu, and
E Gudovan, and
H Ursu
May 1988,
The Journal of clinical endocrinology and metabolism,
L Simionescu, and
L Dumitriu, and
V Dimitriu, and
D Zamfir-Grigorescu, and
G Câmpean, and
E Dumitriu, and
E Balmeş, and
M Simescu, and
E Gudovan, and
H Ursu
March 1989,
Klinische Wochenschrift,
L Simionescu, and
L Dumitriu, and
V Dimitriu, and
D Zamfir-Grigorescu, and
G Câmpean, and
E Dumitriu, and
E Balmeş, and
M Simescu, and
E Gudovan, and
H Ursu
June 2002,
Annals of the New York Academy of Sciences,
